VOR Insider Trading Activity and SEC Form 4 Filings
VOR insider trading summary
Over the past 12 months, insiders at Vor Biopharma Inc. (VOR) reported 48 sales worth $139.7M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $139.7M.
Latest VOR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Peter Kolchinsky | 10% Owner | Sell | $4K (213 @ $19.75) |
| Jul 16, 2026 | Ra Capital Management, L.P. | Insider | Sell | $4K (213 @ $19.75) |
| Jul 16, 2026 | Rajeev M. Shah | 10% Owner | Sell | $4K (213 @ $19.75) |
| Jul 16, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Sell | $4K (213 @ $19.75) |
| Apr 20, 2026 | Rajeev M. Shah | Director | Sell | $2.7M (171,963 @ $15.77) |
| Apr 20, 2026 | RA Capital Healthcare Fund LP | Director | Sell | $2.7M (171,963 @ $15.77) |
| Apr 20, 2026 | Peter Kolchinsky | Director | Sell | $2.7M (171,963 @ $15.77) |
| Apr 20, 2026 | Ra Capital Management, L.P. | Insider | Sell | $2.7M (171,963 @ $15.77) |
| Apr 17, 2026 | Ra Capital Management, L.P. | Insider | Sell | $7.5M (458,411 @ $16.28) |
| Apr 17, 2026 | Rajeev M. Shah | Director | Sell | $7.5M (458,411 @ $16.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.